Patents by Inventor Jeson Sangaralingham

Jeson Sangaralingham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and Methods of Treatment Using CRRL 191
    Publication number: 20240116990
    Abstract: This document provides methods and materials related to selected engineered analogs of atrial natriuretic peptides. For example, this document provides compositions that contain one or more selected engineered analogs of atrial natriuretic peptides provided herein and that have the ability to treat, prevent, or alleviate the symptoms of cardiovascular, cardiorenal, and metabolic disease.
    Type: Application
    Filed: September 15, 2023
    Publication date: April 11, 2024
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: John C. BURNETT, Jr., Shuchong PAN, Sasantha Jeson SANGARALINGHAM, Ye ZHENG
  • ENHANCERS OF PARTICULATE GUANYLYL CYCLASE RECEPTOR A
    Publication number: 20230203025
    Abstract: In some embodiments, the present disclosure provides a compound of Formula (I), as described herein, or a pharmaceutically acceptable salt thereof. Pharmaceutical compositions comprising the compound of Formula (I), and methods of treating, e.g., metabolic diseases using the compound of Formula (I) are also provided.
    Type: Application
    Filed: May 28, 2021
    Publication date: June 29, 2023
    Inventors: John C. Burnett, Jr., Jeson Sangaralingham, Siobhan Malany, Satyamaheshwar Peddibhotla, Paul Mitchell Hershberger, Patrick Maloney, Edward Hampton Sessions, Jr.